Renu Dhingra

Prof. Dr. Renu Dhingra


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Verified
Journal Article
Open access
SMSankat Mochan
Sankat Mochan
MDManoj Kumar Dhingra
Manoj Kumar Dhingra
SGSunil Kumar Gupta
Sunil Kumar Gupta
SSShobhit Saxena
Shobhit Saxena
PAPallavi Arora
Pallavi Arora
RDRenu Dhingra
Renu Dhingra
To explore the role of VEGF in attenuating endoplasmic reticulum stress in placental trophoblast cells. Study was divided into following parts: 1. Serum Analysis of GRP78 and VEGF using sandwich ELISA. 2. Expression of VEGF and GRP78 in placentae by immunohistochemistry (IHC). 3. In Vitro experiments. Status of ER stress markers (GRP78, eIF2α, XBP1, ATF6 and CHOP) was assessed at various time points (8 h, 14 h, 24 h) when trophoblast cells were treated with varying concentration(s) of VEGF and also by adding recombinant VEGF at protein (Immunofluorescence, Western blot) and transcript levels (qRT-PCR). Increased GRP78 and decreased VEGF protein levels in sera and placentae of preeclamptic pregnant women and reduced expression of various ER stress markers at both transcript and protein levels was observed in trophoblast cells when they were exposed to recombinant VEGF thereby indicating positive role of VEGF in alleviating ER stress. Reduced expression of ER stress markers in trophoblast cells against increased VEGF highlighted a new window to explore prospective drugs that can be designed to modulate the activities of various ER stress sensors in order to alleviate ER stress in pregnant women with preeclampsia.

15 September 2023 in Placenta
Verified
Journal Article
Closed access
SGSunil Kumar Gupta
Sunil Kumar Gupta
SMSankat Mochan
Sankat Mochan
PAPallavi Arora
Pallavi Arora
NRNeerja Rani
Neerja Rani
KLKalpana Luthra
Kalpana Luthra
RDRenu Dhingra
Renu Dhingra

12 October 2010
Verified
Journal Article
Closed access
BVBetsy Varughese
Betsy Varughese
NBNeerja Bhatla
Neerja Bhatla
RKRani Kumar
Rani Kumar
SDS N Dwivedi
S N Dwivedi
RDRenu Dhingra
Renu Dhingra

14 July 2006
Verified
Closed access
RDRenu Dhingra
Renu Dhingra
VTVarna Taranikanti
Varna Taranikanti
RKRani Kumar
Rani Kumar

14 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
PAPallavi Arora
Pallavi Arora
SMSankat Mochan
Sankat Mochan
SGSunil Kumar Gupta
Sunil Kumar Gupta
NRNeerja Rani
Neerja Rani
PKPallavi Kshetrapal
Pallavi Kshetrapal
RDRenu Dhingra
Renu Dhingra
Introduction Impaired trophoblast invasion has been observed in early onset Preeclampsia patients (EOPE). Trophoblast cell invasion during human placentation is majorly regulated by the balance between MMPs 2, 9 and their inhibitors [tissue inhibitors of matrix metalloproteinases (TIMPs 1, 2)]. Exogenous NaHS (hydrogen sulphide donor) treatment was shown to significantly increase the expression levels of matrix metalloproteinases (MMPs 2, 9) in human bladder cancer EJ cells. Epigentically, the gene expression of hydrogen sulphide synthesising enzyme CBS (cystathionine β-synthase) could be further regulated by various mi-RNAs via the transcription factors like Sp1. Specificity protein 1 (Sp1) has been identified as a target gene for miR-22 to regulate the invasion and metastasis of gastric cancer cells. However, the mechanism of MMPs regulation by either CBS, Sp1 and miRNA-22 in the pregnancies having EOPE is not known. Aims and Objectives To determine and compare the expression of MMPs 2, 9, TIMPs 1, 2, CBS, Sp1 and miRNA-22 in EOPE patients and normotensive, non-proteinuric controls. Materials and methods 100 pregnant women were enrolled from Department of Obstetrics and Gynaecology, AIIMS, New Delhi, India. EOPE women (n=50) after clinical diagnosis as per ACOG guidelines were enrolled as cases and normotensive, non-proteinuric pregnant women (n=50) were enrolled as controls. Protocol of the study was approved by Institute Ethics Committee, AIIMS, New Delhi. 5 ml of venous blood was collected from all the recruited women (2.5 ml in each EDTA and sera vial) followed by plasma and sera separation. Plasma samples were used subsequently to determine gene expression of MMPs 2, 9, TIMPs 1, 2, CBS, Sp1 and miRNA-22 by qRT-PCR and sera samples were used to estimate their protein levels by ELISA. Data were analyzed by STATA 14 and Graph Pad Prism 8. Results Significantly down regulated expression of MMPs 2, 9, CBS and Sp1 whereas up regulated expression for that of TIMPs 1, 2 was observed in EOPE patients as compared to healthy pregnant women at both transcription and translation levels. Expression of miR-22 (pre miR-22 and miR-22-3p) was found to be significantly elevated in EOPE patients as compared to normotensive, non-proteinuric controls. Conclusion This is the very first study of its kind which implicates that down regulated MMPs 2, 9, CBS, Sp1 levels and simultaneously upregulation of miR-22 expression in EOPE patients could have some association. In vitro experiments are needed to prove their association which if proven may provide a new, potential therapeutic target to treat early onset Preeclampsia.

28 December 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSankat Mochan
Sankat Mochan
MDManoj Kumar Dhingra
Manoj Kumar Dhingra
BVBetsy Varghese
Betsy Varghese
SGSunil Kumar Gupta
Sunil Kumar Gupta
SSShobhit Saxena
Shobhit Saxena
RDRenu Dhingra
Renu Dhingra
Background: The concentration of sFlt-1, a major anti-angiogenic protein in maternal circulation has been seen to be raised in preeclamptic pregnancies. Endoplasmic reticulum (ER) stress represents one of the three (immunological, oxidative and ER stress) major stresses which placenta undergoes during pregnancies. The present study is designed to investigate the role of sFlt-1 in induction of ER stress in trophoblast cells. Materials and Methods: Maternal serum levels of anti-angiogenic protein sFlt-1 and central regulator of unfolded protein response GRP78 was measured using sandwich ELISA. The expression of various ER stress markers (GRP78, eIF2α, XBP1, ATF6 and apoptotic protein CHOP) were analyzed depending on various treatments given to the trophoblast cells using Immunofluorescence, western blot and q-RT PCR. Results: Increased expression of ER stress markers (GRP78, eIF2α, XBP1 ATF6 and apoptotic protein CHOP) was detected in the placental trophoblast cells treated with raised concentration of sFlt-1. Conclusion: Significant upregulated expression of ER stress markers in trophoblast cells exposed with increased concentration of sFlt-1 suggested that it may be one of the anti-angiogenic factors present in maternal sera which not only contributes to oxidative stress but also may cause endoplasmic reticulum stress.